We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current KPRX market cap is 13.48M. The company's latest EPS is USD -0.5040 and P/E is -1.01.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.7M | -2.64M | -1.92M | -2.63M | -5.92M |
| Net Income | -5.12M | -2.5M | -1.87M | -2.61M | -6.29M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.69M | 12k | 0 | 0 | 0 |
| Operating Income | -7.11M | -8.21M | -16.94M | -12.31M | -12.59M |
| Net Income | -7.1M | -8.09M | -16.4M | -13.58M | -13.05M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 17.66M | 18.68M | 16.53M | 19.89M | 15.9M |
| Total Liabilities | 7.14M | 7.27M | 6.37M | 6.24M | 7.79M |
| Total Equity | 10.52M | 11.41M | 10.16M | 13.64M | 8.1M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 10.11M | 15.16M | 18.06M | 18.68M | 13.71M |
| Total Liabilities | 3.49M | 8.16M | 8.83M | 7.27M | 7.6M |
| Total Equity | 6.62M | 7M | 9.23M | 11.41M | 6.11M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.3M | -10.43M | -3.07M | -4.46M | -6.98M |
| Investing | 6k | 6k | N/A | N/A | N/A |
| Financing | 5.38M | 8.62M | 513k | 6.45M | 6.45M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.15M | -7.32M | -10.89M | -10.43M | -9.56M |
| Investing | N/A | -244k | -157k | 6k | N/A |
| Financing | 3.92M | 5M | 17.8M | 8.62M | 5.97M |
| Market Cap | 13.48M |
| Price to Earnings Ratio | -1.01 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 5.38 |
| Price to Book Ratio | 2.16 |
| Dividend Yield | - |
| Shares Outstanding | 25.88M |
| Average Volume (1 week) | 95.27k |
| Average Volume (1 Month) | 209.67k |
| 52 Week Change | -80.71% |
| 52 Week High | 2.70 |
| 52 Week Low | 0.45111 |
| Spread (Intraday) | 0.03 (6.76%) |
| Company Name | Kiora Pharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://kiorapharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
